Valeant’s looming M&A hiatus deals blow to investment banks

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 22 October, 2015 by The TZ Newswire Staff

Valeant’s looming M&A hiatus deals blow to investment banks

The controversy surrounding Valeant Pharmaceuticals’ strategy and its market slide this week are bad news for Wall Street investment banks that stand to lose one of their best clients. The specialty drug …

See also
- Next Article Currencies: Euro extends losses; investors turn to next week’s FOMC meeting
- Previous Article Futures Movers: Oil prices rise, but stronger dollar lurks in the background
Editorial Calender

October 2015

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30 31

« Sep Nov »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 22 October, 2015 by The TZ Newswire Staff

Valeant’s looming M&A hiatus deals blow to investment banks

See also

Editorial Calender

Recent Tags